Literature DB >> 10732792

The role of cytokines in both the normal and malignant ovary.

M A Nash1, G Ferrandina, M Gordinier, A Loercher, R S Freedman.   

Abstract

Normal ovarian tissue is rich in cytokines. Cytokines and chemokines are important in the physiology of ovarian function and of ovulation. Cytokines and chemokines may recruit cytokine-producing lymphocytes to the site of a developing follicle, and cytokines appear to play an important role in pre and post follicle development. Most of the same cytokines that are found in normal ovarian tissue are also found in association with malignancy in contrast to their functions in normal tissues. It is reasonable to assume that the functions of cytokines associated with malignancy may serve to promote the unregulated growth if tumor cells and metastasis. It is also likely that cytokines produced by tumors will modulate immune responses that favor tumor progression. In the following review, we have highlighted those functions of cytokines that have been identified as having the most significant impact on tumor growth and development. By examining activities of these cytokines in normal and in malignant ovarian tissues, it is hoped that future possible avenues for investigation may be opened up and that the results of these investigations will lead to strategies that can modulate the production or the activity of the cytokines leading to the growth of tumors or their metastases. Such strategies now fall under the general discipline of bioimmunotherapy. This is an expanding discipline as more is learned about growth regulation in cancer, and with the availability and rapid development of new molecules for therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10732792     DOI: 10.1677/erc.0.0060093

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  27 in total

1.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

2.  Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; Ai-Qun Wei; Gregory Robertson; David L Morris
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

3.  Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase.

Authors:  Yuan-Ping Han; Yih-Dar Nien; Warren L Garner
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

Review 4.  Microenvironment and pathogenesis of epithelial ovarian cancer.

Authors:  Antonio F Saad; Wei Hu; Anil K Sood
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

5.  Circulating inflammation markers and risk of epithelial ovarian cancer.

Authors:  Tess V Clendenen; Eva Lundin; Anne Zeleniuch-Jacquotte; Karen L Koenig; Franco Berrino; Annekatrin Lukanova; Anna E Lokshin; Annika Idahl; Nina Ohlson; Goran Hallmans; Vittorio Krogh; Sabina Sieri; Paola Muti; Adele Marrangoni; Brian M Nolen; Mengling Liu; Roy E Shore; Alan A Arslan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

Review 6.  Chemokines: key players in cancer progression and metastasis.

Authors:  Rajesh Singh; James W Lillard; Shailesh Singh
Journal:  Front Biosci (Schol Ed)       Date:  2011-06-01

7.  Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.

Authors:  Federica Barbieri; Adriana Bajetto; Tullio Florio
Journal:  J Oncol       Date:  2009-12-14       Impact factor: 4.375

8.  Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors.

Authors:  Nathalie L G Sieben; Sandra M Kolkman-Uljee; Adrienne M Flanagan; Saskia le Cessie; Anne-Marie Cleton-Jansen; Cees J Cornelisse; Gert Jan Fleuren
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

9.  A serum based analysis of ovarian epithelial tumorigenesis.

Authors:  Brian Nolen; Adele Marrangoni; Liudmila Velikokhatnaya; Denise Prosser; Matthew Winans; Elesier Gorelik; Anna Lokshin
Journal:  Gynecol Oncol       Date:  2008-11-12       Impact factor: 5.482

10.  Bcl-2 expression is altered with ovarian tumor progression: an immunohistochemical evaluation.

Authors:  Nicole S Anderson; Leslie Turner; Sandra Livingston; Ren Chen; Santo V Nicosia; Patricia A Kruk
Journal:  J Ovarian Res       Date:  2009-10-25       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.